Specifications
- Pk:100 µG
- Protein/peptide type:Recombinant
- Source:HEK293 cells
- Biological activity:Measured by its binding ability in a functional ELISA Immobilized mouse PCSK9 at 10μg/ml (100μl/well) can bind biotinylated rhLDLR. The EC50 of biotinylated human LDLR is 0. 1μg/ml.
- Protein synonyms:HCHOLA3|PCSK9|LDLCQ1|PC9|NARC1|FH3
- Protein/peptide name:PCSK9
- Purity:>97% as determined by SDS-PAGE.
- Molecular weight:72 kDa
- Formulation:Lyophilized, PBS, pH7.4
- Tested applications:Western Blot
Specifications
About this item
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is also known as NARC1 (neural apoptosis regulated convertase), is a newly identified subtilase belonging to the peptidase S8 subfamily. Mouse PCSK9 is synthesized as a soluble zymogen, and undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted active enzyme with a broad alkaline pH optimum. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. PCSK9 may also have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).